Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
Morgan
G
G
D000230:Adenocarcinoma / Q000209:etiology / Q000473:pathology* / Q000517:prevention & control; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D001471:Barrett Esophagus / Q000209:etiology / Q000473:pathology* / Q000517:prevention & control; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D004938:Esophageal Neoplasms / Q000209:etiology / Q000473:pathology* / Q000517:prevention & control; D006801:Humans; D008679:Metaplasia; D011230:Precancerous Conditions / Q000209:etiology / Q000473:pathology* / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin